Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 2.34%, near the low end of its 5-year range (0.00%–12.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 1.63%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
1.63%
DEBT TO ASSETS RATIO AVG 3Y
2.22%
DEBT TO ASSETS RATIO AVG 5Y
2.34%
DEBT TO ASSETS RATIO AVG 10Y
2.27%
DEBT TO ASSETS RATIO AVG 15Y
9.47%
DEBT TO ASSETS RATIO AVG 20Y
3.36%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Palisade Bio, Inc.
Market Cap
$258.63M
Debt to Assets Ratio
0.00%
TTM Avg
1.63%
3Y Avg
2.22%
5Y Avg
2.34%
Market Cap
$259.12M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.14M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.49M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.56M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.27M
Debt to Assets Ratio
0.31%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$255.88M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palisade Bio, Inc. (PALI) | $258.63M | 0.00% | 1.63% | 2.22% | 2.34% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | 0.03% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 0.01% | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | 0.40% | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | 0.03% | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.47M | 0.03% | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | 0.31% | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 0.13% | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | 0.55% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
24.26
Interest Coverage
-1805.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.05% |
| 2025-09-30 | 3.03% |
| 2025-06-30 | 5.07% |
| 2025-03-31 | 0.71% |
| 2024-12-31 | 1.55% |
| 2024-09-30 | 3.82% |
| 2024-06-30 | 3.91% |
| 2024-03-31 | 1.45% |
| 2023-12-31 | 2.63% |
| 2023-09-30 | 2.92% |
| 2023-06-30 | 3.70% |
| 2023-03-31 | 1.91% |
| 2022-12-31 | 2.56% |
| 2022-09-30 | 4.25% |
| 2022-06-30 | 12.49% |
| 2022-03-31 | 0.78% |
| 2021-12-31 | 1.59% |
| 2021-09-30 | 4.46% |
| 2021-06-30 | 8.98% |
| 2021-03-31 | 84.13% |
| 2020-12-31 | 47.07% |
| 2020-09-30 | 65.54% |
| 2020-06-30 | 0.95% |
| 2020-03-31 | 1.49% |
| 2019-12-31 | 2.75% |
| 2019-09-30 | 6.18% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 13.51% |
| 2016-12-31 | 16.39% |
| 2016-09-30 | 57.15% |
| 2016-06-30 | 44.42% |
| 2016-03-31 | 68.76% |
| 2015-12-31 | 53.34% |
| 2015-09-30 | 42.96% |
| 2015-06-30 | 34.06% |
| 2015-03-31 | 28.84% |
| 2014-12-31 | 29.44% |
| 2014-09-30 | 19.26% |
| 2014-06-30 | 19.52% |
| 2014-03-31 | 19.60% |
| 2013-12-31 | 39.65% |
| 2013-09-30 | 39.90% |
| 2013-06-30 | 55.08% |
| 2013-03-31 | 49.01% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.40% |
| 2007-06-30 | 0.42% |
| 2007-03-31 | 0.39% |
| 2006-12-31 | 1.47% |
| 2006-09-30 | 1.16% |
| 2006-06-30 | 0.98% |
